<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (aPL) have been reported to occur in several conditions other than <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, including <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We herein report the case of a 21-year-old Japanese woman with <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">Parvovirus B19 infection</z:e>, who developed multiple <z:e sem="disease" ids="C0034065" disease_type="Disease or Syndrome" abbrv="">pulmonary emboli</z:e> associated with aPL, a <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and IgM anticardiolipin antibody </plain></SENT>
<SENT sid="2" pm="."><plain>Eight weeks later, <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> spontaneously disappeared and <z:mpath ids='MPATH_458'>normal</z:mpath> pulmonary flow was observed </plain></SENT>
<SENT sid="3" pm="."><plain>Considering the high prevalence of <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">Parvovirus B19 infection</z:e>, we should be aware of <z:mp ids='MP_0005048'>thrombosis</z:mp> associated with transient aPL antibodies in this <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious disease</z:e> </plain></SENT>
</text></document>